Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
Johnson and Johnson

Last Updated: March 21, 2023

Details for New Drug Application (NDA): 020753

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

NDA 020753 describes AROMASIN, which is a drug marketed by Pfizer and is included in one NDA. It is available from two suppliers. Additional details are available on the AROMASIN profile page.

The generic ingredient in AROMASIN is exemestane. There are fifteen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the exemestane profile page.
Summary for 020753
Formulation / Manufacturing:see details
Pharmacology for NDA: 020753
Mechanism of ActionAromatase Inhibitors
Suppliers and Packaging for NDA: 020753
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
AROMASIN exemestane TABLET;ORAL 020753 NDA Pharmacia & Upjohn Company LLC 0009-7663 0009-7663-04 30 TABLET in 1 BOTTLE (0009-7663-04)
AROMASIN exemestane TABLET;ORAL 020753 NDA AUTHORIZED GENERIC Greenstone LLC 59762-2858 59762-2858-1 30 TABLET, SUGAR COATED in 1 BOTTLE (59762-2858-1)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG
Approval Date:Oct 21, 1999TE:ABRLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.